AA

Arpit Anil Save

Active Director Director DIN 02863344
DIN 02863344 First appointment Apr 2010 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 2 active board seats
Past companies 5 historical roles
Total affiliations 7 Since Apr 2010
Shareholding value •••• Premium profile

About Arpit Anil Save

Data last updated:

Arpit Anil Save is a Director at Savera Pharmaceuticals Private Limited (since 2024) and Managing Director at Avangii Labs Private Limited (since 2024). The companies operate in Pharma and Healthcare. The 2 current companies with reported revenue have a combined latest revenue of ₹13.09 Cr; the largest is Savera Pharmaceuticals Private Limited at ₹11.53 Cr (FY 2025). Earlier, Arpit Anil Save was a Whole-Time Director at Rv Lifesciences Limited (2010–2016) and Director at Atra Labs Private Limited (2011–2016) and 3 more.

DIN 02863344
Primary Designation Director
Industry Pharma
First Appointment 01 Apr 2010
Oldest Company Age 30 yrs
Largest company Savera Pharmaceuticals Private Limited · ₹11.53 Cr (FY 2025)
Combined revenue ₹13.09 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director17 Jan 20241996₹11.53 Cr (FY 2025)Active
Avangii Labs Private Limited U24290MH2022PTC392672
Managing Director22 Jun 20242022₹1.56 Cr (FY 2025)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Rv Lifesciences Limited U24230MH1991PLC063442
Whole-Time Director01 Apr 20101991₹193 Cr (FY 2025)Active
Atra Labs Private Limited U73100MH2011PTC222310
Director23 Sep 20112011₹69.3 Lakh (FY 2025)Active
Amrit Life Science Private Limited U24100MH2010PTC206325
Director07 Aug 20102010Active
Atra Biotech Private Limited U24233MH2011PTC220740
Director09 Aug 20112011Strike Off
Director02 Sep 20112011Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Atra Biotech Private Limited
Avanti Clinical Research Laboratories Private Limited
Savera Pharmaceuticals Private Limited
Avangii Labs Private Limited
Premium access

Shareholding and investment profile for Arpit Anil Save

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Arpit Anil Save

Arpit Anil Save currently holds 2 directorships: Savera Pharmaceuticals Private Limited (Director, since 17 Jan 2024, revenue ₹11.53 Cr (FY 2025)); Avangii Labs Private Limited (Managing Director, since 22 Jun 2024, revenue ₹1.56 Cr (FY 2025)).

Arpit Anil Save was first appointed on 01 Apr 2010 as Whole-Time Director at Rv Lifesciences Limited. The most recent appointment on record is 22 Jun 2024 at Avangii Labs Private Limited.

The 2 current companies of Arpit Anil Save that report revenue have a combined latest revenue of ₹13.09 Cr: Savera Pharmaceuticals Private Limited ₹11.53 Cr (FY 2025); Avangii Labs Private Limited ₹1.56 Cr (FY 2025).

Arpit Anil Save held 5 earlier board appointments: Rv Lifesciences Limited (Whole-Time Director, 01 Apr 2010 to 15 Mar 2016); Atra Labs Private Limited (Director, 23 Sep 2011 to 15 Mar 2016); Amrit Life Science Private Limited (Director, 07 Aug 2010 to 10 Aug 2022); Atra Biotech Private Limited (Director, from 09 Aug 2011); Avanti Clinical Research Laboratories Private Limited (Director, from 02 Sep 2011).

The current boards of Arpit Anil Save's companies include Ajit Moreshwar Save (Savera Pharmaceuticals Private Limited), Anil Moreshwar Save (Savera Pharmaceuticals Private Limited), Anjali Anil Save (Savera Pharmaceuticals Private Limited), Rajeev Yadav Churi (Savera Pharmaceuticals Private Limited), Himangi Arpit Save (Avangii Labs Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available